期刊文献+

Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro 被引量:6

Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro
下载PDF
导出
摘要 AIM: To investigate whether octreotide can inhibit the growth of human gallbladder cancer cells in vitro and to elucidate the antineoplastic mechanism of octreotide in gallbladder cancer. METHODS: A human gallbladder cancer cell line, GBC-SD, was cultured in vitro. The antiproliferative effects of octreotide were examined by means of an MTT assay and a colony forming ability assay. Morphological variation was investigated under scanning electron microscopy and transmission electron microscopy. Cell cycle analysis and apoptosis rate was evaluated by flow cytometry (FCM) after staining by propidium iodide. DNA fragmentation was assayed by agarose gel electrophoresis. Immunohistochemical staining was performed to evaluate the expressions of mutant-type p53 and bcl-2. RESULTS: The growth curve and colony forming ability assay showed significant inhibition of octreotide to the proliferation of GBC-SD cells in culture in a time- and dosedependent manner. After exposure to octreotide, GBC-SD cells showed typically apoptotic characteristics, including morphological changes of chromatin condensation, vacuolar degeneration, nucleus fragmentation and apoptotic body formation. In FCM profile apoptotic cells showed increased sub-G1 peaks in the octreotide group, significantly higher than the control group (P=0.013). There was also anaugmentation in the cell proportion of G0/G1 phase (P=0.015), while the proportion of S phase and G2/M phase remained unchanged (P=0.057 and P=0.280, respectively). DNA agarose gel electrophoresis displayed a ladder after exposure to 1000 nmol/L octreotide. After being treated with octreotide, the expressions of both mutant-type p53 and bd-2 decreased considering the percentage of positive cells (P<0.05). CONCLUSION: Octreotide has a negative action to the proliferation of GBC-SD cells, and the mechanism may be related to cytostatic and cytotoxic effects. The reduction of mutant-type p53 and bcl-2 expressions may be associated with the apoptosis induced by octreotide. AIM:To investigate whether octreotide can inhibit the growth of human gallbladder cancer cells in vitro and to elucidate the antineoplastic mechanism of octreotide in gallbladder cancer. METHODS:A human gallbladder cancer cell line,GBC-SD, was cultured in vitro.The antiproliferative effects of octreotide were examined by means of an MTT assay and a colony forming ability assay.Morphological variation was investigated under scanning electron microscopy and transmission electron microscopy.Cell cycle analysis and apoptosis rate was evaluated by flow cytometry (FCM) after staining by propidium iodide.DNA fragmentation was assayed by agarose gel electrophoresis.Immunohistochemical staining was performed to evaluate the expressions of mutant-type p53 and bc1-2. RESULTS:The growth curve and colony forming ability assay showed significant inhibition of octreotide to the proliferation of GBC-SD cells in culture in a time-and dose- dependent manner.After exposure to octreotide,GBC-SD cells showed typically apoptotic characteristics,including morphological changes of chromatin condensation,vacuolar degeneration,nucleus fragmentation and apoptotic body formation.In FCM profile apoptotic cells showed increased sub-G_1 peaks in the octreotide group,significantly higher than the control group (P=0.013).There was also an augmentation in the cell proportion of G_0/G_1 phase (P=0.015),while the proportion of S phase and G_2/M phase remained unchanged (P=0.057 and P=0.280,respectively). DNA agarose gel electrophoresis displayed a ladder after exposure to 1000 nmol/L octreotide.After being treated with octreotide,the expressions of both mutant-type p53 and bc1-2 decreased considering the percentage of positive cells (P<0.05). CONCLUSION:Octreotide has a negative action to the proliferation of GBC-SD cells,and the mechanism may be related to cytostatic and cytotoxic effects.The reduction of mutant-type p53 and bc1-2 expressions may be associated with the apoptosis induced by octreotide.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第7期1043-1046,共4页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献4

二级参考文献21

共引文献73

同被引文献26

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部